A Study on Laboratory Details and Cost of Dengue Fever
Not Applicable
- Conditions
- Health Condition 1: B338- Other specified viral diseases
- Registration Number
- CTRI/2020/12/029749
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients diagnosed with dengue fever.
Patients admitted in the hospital minimum of 2 days.
Patients admitted in the hospital during january 2018 to december 2019.
Exclusion Criteria
Patients with incomplete records.
Pregnant patients.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie dengue fever pathogenesis in B338 viral disease patients?
How does the cost of illness in dengue fever compare with other flavivirus infections like Zika or West Nile?
Are there specific biomarkers for early detection of dengue fever in clinical settings?
What are the most effective management strategies for dengue-related adverse events in resource-limited areas?
How do observational studies contribute to understanding dengue fever treatment economics and outcomes?